Trial Profile
A study to evaluate the effect of Tocilizumab on IgG levels in HLA-sensitized Kidney transplant patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Oct 2016
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary) ; Rituximab
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 18 Oct 2016 New trial record